The EPA is calling for informationon the use of fluazinam in Aotearoa New Zealand. Some of the commonly named products containing fluazinam are:
Ohayo 500 SC
Agpro Fluazinam 500
Flick 500 SC Fungicide
This is an opportunity for you, as interested parties and/or stakeholders, to provide information on fluazinam-containing substances that are available in Aotearoa New Zealand, and how those substances are used. We are looking for any relevant information industry, users, other interested parties or the public can provide to us relating to the current use, practices, and benefits of fluazinam substances. This includes any information relating to the effects of the substances, positive or adverse; toxicology; ecotoxicology; environmental fate studies; or monitoring results.
We particularly request data that relates to dermal absorption, acceptable operator exposure limits, risks to aquatic organisms and risks to soil-dwelling organisms.
As the current risk management framework is driven to a large extent by industry requirements, we want to better our understanding of current industry requirements, such as:
-the identification and nature of the risks being managed
-what measures are implemented to manage risks
-the effectiveness of the current requirements in managing risks to human health and the environment
-how the industry requirements align with other regulatory requirements under different pieces of legislation (eg Hazardous Substances and New Organisms Act 1996, Health and Safety at Work Act 2015 and Resource Management Act 1991).
The closing date to submit a response has been extended until Wednesday 30 November 2022.[/b]
Webinars for interested parties[/b]
The EPA will be conducting one or more webinars in mid-October to provide further information on this call for information and the possibility of a reassessment. Please register your interest for participating in a webinar by emailing [url=mailto:email@example.com]firstname.lastname@example.org[/url] or by answering question 1.2. Webinars will only be held if there is sufficient interest. We are anticipating scheduling a webinar for industry, Māori, NGO’s and/or members of the public. Whether these will be one session or separate sessions will be decided based on interest levels. This will be an opportunity to learn about the fluazinam call for information and ask questions.
Responding to the call for information[/b]
Please read the important information below which details how the information provided will be used. You are welcome to answer all of the questions or only those that are relevant to you.
How[/b] [b]we will use the information[/b]
This information will be used to prepare an application for reassessment, to determine whether the EPA should undertake a modified or full reassessment of fluazinam, and to inform that reassessment process. Interested parties will have an opportunity to make formal submissions on our assessment and proposal once an application has been lodged. Your information may be made publicly available. We may publish or otherwise make available all or part of your response. This may include your name but not your contact details. We acknowledge that some information may be commercially sensitive or be otherwise regarded as confidential. If you believe any of the information you are providing should not be made publicly available, please clearly indicate this within your response, and give the reasons, so we can consider this before publishing any information.
Privacy statement [/b]
Any personal information you supply when providing information will be used only in relation to this call for information. You have a right to access and correct any personal information held by us, by contacting the EPA at [url=mailto:email@example.com][b]firstname.lastname@example.org[/b][/url]. You may request that your personal information (such as your name) be with held from publicly available information. We will not make your personal contact details publicly available.
Official Information Act. The Official Information Act 1982 (OIA) applies to all information held by the EPA (subject to section 55 of the Hazardous Substances and New Organisms Act 1996), and information may be released under the OIA unless there are grounds to withhold it. If you consider any part of your response is confidential, please clearly label it as such and include the reasons why you think the information is confidential (eg, you may consider some information to be commercially sensitive). Further information on the OIA is at [url=http://www.ombudsman.parliament.nz/][b]www.ombudsman.parliament.nz[/b][/url]
Please fill in the form below, then click Continue to review your submission. At any time you may click Save and Exit so that you can return later.